APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 36 filers reported holding APTEVO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58 | -50.4% | 175,980 | +119.5% | 0.00% | – |
| Q2 2023 | $117 | +4.5% | 80,186 | +45.8% | 0.00% | – |
| Q1 2023 | $112 | -26.3% | 54,986 | -16.0% | 0.00% | – |
| Q4 2022 | $152 | -99.9% | 65,486 | -4.2% | 0.00% | – |
| Q3 2022 | $208,000 | -16.8% | 68,386 | -2.1% | 0.00% | – |
| Q2 2022 | $250,000 | -27.7% | 69,886 | +18.7% | 0.00% | – |
| Q1 2022 | $346,000 | -36.0% | 58,886 | -14.3% | 0.00% | -100.0% |
| Q4 2021 | $541,000 | -75.6% | 68,686 | -52.1% | 0.00% | -66.7% |
| Q3 2021 | $2,214,000 | -38.3% | 143,419 | -10.3% | 0.00% | -25.0% |
| Q2 2021 | $3,587,000 | -43.8% | 159,923 | -23.6% | 0.00% | -50.0% |
| Q1 2021 | $6,385,000 | -31.5% | 209,223 | -17.8% | 0.01% | -20.0% |
| Q4 2020 | $9,325,000 | +318.9% | 254,423 | -13.1% | 0.01% | +400.0% |
| Q3 2020 | $2,226,000 | +16.9% | 292,867 | +28.5% | 0.00% | 0.0% |
| Q2 2020 | $1,904,000 | +184.2% | 227,967 | +26.0% | 0.00% | +100.0% |
| Q1 2020 | $670,000 | – | 180,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,334,169 | $440,276 | 0.32% |
| ARMISTICE CAPITAL, LLC | 1,235,000 | $407,550 | 0.01% |
| Divergent Wealth Advisors | 10,000 | $3,300 | 0.00% |
| FIFTH THIRD BANCORP | 291 | $96 | 0.00% |
| FRANKLIN RESOURCES INC | 10,997 | $3,629 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $2 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 142 | $47 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,562 | $515 | 0.00% |
| NORTHERN TRUST CORP | 14,121 | $4,660 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |